Dr. John Hoefs, MD, is a recognized authority on liver disease assessment and management. He understands clinical liver disease and developed the QLSS methods to measure hepatic function, fibrosis, hepatic and spleen volume and cirrhosis.
He has been involved in multiple studies documenting the clinical value of the QLSS techniques in patients with CLD. He has collected data and experience on over 20,000 patients with chronic liver disease. He has published extensively.
He serves as the Chief Operating Officer of HEPATIQ LLC.